Kineta Expands Board of Directors with Biotech Industry Leaders Kim Drapkin and Scott Dylla tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.
Kineta, Inc. (NASDAQ:KA – Get Rating) CFO Keith Baker bought 5,000 shares of Kineta stock in a transaction dated Friday, June 16th. The shares were bought at an average cost of $2.92 per share, with a total value of $14,600.00. Following the completion of the transaction, the chief financial officer now directly owns 11,880 shares […]
Kineta, Inc. (NASDAQ:KA – Get Rating) – HC Wainwright dropped their Q2 2023 earnings estimates for Kineta in a report released on Thursday, May 18th. HC Wainwright analyst R. Burns now expects that the company will earn ($0.72) per share for the quarter, down from their previous estimate of ($0.68). HC Wainwright currently has a […]
Kineta Set to Join Russell Microcap® Index streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Kineta (NASDAQ:KA – Get Rating) and Jazz Pharmaceuticals (NASDAQ:JAZZ – Get Rating) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their dividends, institutional ownership, valuation, risk, analyst recommendations, earnings and profitability. Insider & Institutional Ownership 22.0% of Kineta shares are held by […]